Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients

Multiple Sclerosis

Volumn 15, Issue 11, 2009, Pages 1263-1270

  Smestad, Cathrine ^a   Sandvik, L ^a   Celius, E G ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cause of death; Epidemiology; Multiple sclerosis; Norway; Survival

Indexed keywords

ACCIDENT; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DEATH CERTIFICATE; DECUBITUS; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL INFORMATION; MENINGITIS; MORTALITY; MULTIPLE SCLEROSIS; NORWAY; ONSET AGE; RELAPSE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SCHOOL CHILD; SUICIDE; SURVIVAL; SURVIVAL TIME; URINARY TRACT INFECTION;

EID: 70450191763     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509107010     Document Type: Article

References (27)

1. Bramwell B. The prognosis in disseminated sclerosis; duration in two hundred cases of disseminated sclerosis. Edinb Med J 1917; 18: 15-23.
2. Carter S., Sciarra D., Merritt HH The course of multiple sclerosis as determined by autopsy proven cases. Res Publ Assoc Res Nerv Ment Dis 1950; 28: 471-511.
3. Lazarte JA Multiple sclerosis: Prognosis for ambulatory and nonambulatory patients. Res Publ Assoc Res Nerv Ment Dis 1950; 28: 512-23.
4. Ipsen Jr J. Life expectancy and probable disability multiple sclerosis. N Engl J Med 1950; 243: 909-13.
5. Phadke JG Survival pattern and cause of death in patients with multiple sclerosis: Results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatr 1987; 50: 523-31.
6. Riise T., Gronning M., Aarli JA, Nyland H., Larsen JP, Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol 1988; 41: 1031-36.
7. Wallin MT, Page WF, Kurtzke JF Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain 2000; 123: 1677-87.
8. Bronnum-Hansen H., Koch-Henriksen N., Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844-50.
9. Hirst C., Swingler R., Compston DA, Ben-Shlomo Y., Robertson NP Survival and cause of death in multiple sclerosis: A prospective population-based study. J Neurol Neurosurg Psychiatr 2008; 79: 1016-21.
10. Grytten TN, Lie SA, Aarseth JH, Nyland H., Myhr KM Survival and cause of death in multiple sclerosis: Results from a 50-year follow-up in Western Norway. Mult Scler 2008.
11. Leray E., Morrissey SP, Yaouanq J., et al. Long-term survival of patients with multiple sclerosis in West France. Mult Scler 2007; 13: 865-74.
12. Koch-Henriksen N., Bronnum-Hansen H., Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: Results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatr 1998; 65: 56-9.
13. Malmgren RM, Valdiviezo NL, Visscher BR, et al. Underlying cause of death as recorded for multiple sclerosis patients: Associated factors. J Chronic Dis 1983; 36: 699-705.
14. Smestad C., Sandvik L., Holmoy T., Harbo HF, Celius EG Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008; 255: 49-55.
15. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: Prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001; 8: 463-9.
16. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
17. Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-11.
18. World Health Organization. (1992). International statistical classification of diseases and related health problems. Geneva: WHO, 1992.
19. Sadovnick AD, Ebers GC, Wilson RW, Paty DW Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992; 42: 991-4.
20. Bronnum-Hansen H., Stenager E., Hansen T., Koch-Henriksen H. Survival and mortality rates among Danes with MS. Int MS J 2006; 13: 66-71.
21. Allen IV, Millar JH, Hutchinson MJ General disease in 120 necropsy-proven cases of multiple sclerosis. Neuropathol Appl Neurobiol 1978; 4: 279-84.
22. Sadovnick AD, Eisen K., Ebers GC, Paty DW Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193-96.
23. Sumelahti ML, Tienari PJ, Wikstrom J., Salminen TM, Hakama M. Survival of multiple sclerosis in Finland between 1964 and 1993. Mult Scler 2002; 8: 350-5.
24. Bronnum-Hansen H., Stenager E., Nylev SE, Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatr 2005; 76: 1457-59.
25. Fredrikson S., Cheng Q., Jiang GX, Wasserman D. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 2003; 22: 146-52.
26. Midgard R., Albrektsen G., Riise T., Kvale G., Nyland H. Prognostic factors for survival in multiple sclerosis: A longitudinal, population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatr 1995; 58: 417-21.
27. Levic ZM, Dujmovic I., Pekmezovic T., et al. Prognostic factors for survival in multiple sclerosis. Mult Scler 1999; 5: 171-78.